17
7/23/2019 i Bd Compar Compet Trials http://slidepdf.com/reader/full/i-bd-compar-compet-trials 1/17 1 Cevac IBD L comparison to competitors Cevac IBD L comparison to competitors Comparative studies of Cevac IBD L and some of its main competitors Results C. Cazaban International Technical Manager

i Bd Compar Compet Trials

Embed Size (px)

Citation preview

Page 1: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 1/17

1

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

Comparative studies of Cevac IBD L and some

of its main competitors

Results

C. Cazaban

International Technical Manager

Page 2: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 2/17

2

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

Stud !o." #D$%&"'%(&&)* +. ,orgach-  safet and serolog response

in S/, birds

10-day old SPF birds.

Ocular vaccination with

• Nobilis 228E (co!"titor 1#$ or 

• %& (co!"titor 2#$

•'"vac &) *.

+0 birds !"r ,rou! (incl. control ,rou!#

Page 3: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 3/17

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

Kinetics of virus replication in the bursa of Fabricius in 10-day oldSPF birds (study no.1)

0

1

2

3

!

"

2 3 # 1! 21

$ays of the study

   %  u  r  s  a

   h   i  s   t  o   l  o  &  y  s  c  o  r  e   (   '  u

  r   P   h   )

opetitor 1 opetitor 2 evac *%$ + ontrols

Page 4: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 4/17

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

%,% inde in 10-day old SPF birds on $2 (study no.1)

0

0/1

0/2

0/3

0/

0/!

0/"

0/#

%% inde

opetitor 1 opetitor 2 evac *%$ +

*nterediate

ot

Page 5: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 5/17

/

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

Serolo&y curve in 10-day old SPF birds (study no.1)

0123

!"#

10111213

0 # 1! 21 2

$ays of the study

   *   %

   $         t   i   t  r  e   (   i  n   l  o  &

   2   )

opetitor 1 opetitor 2 evac *%$ + ontrols

*

*

*: statistical di fference

Page 6: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 6/17

Page 7: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 7/17

7

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

Stud !o.( Immunosuppression stud #D$0&"10(&&)* $. /ala- 

11-day old SPF birds. /0 birds !"r ,rou!.

Ocular vaccination ()ay 0# with

• Nobilis 228E (co!"titor 1#$• %& (co!"titor 2#$

• Poulvac &ursa Plus (co!"titor #$

• &) &l"n (co!"titor #$ or 

• '"vac &) *.

Ocular vaccination with '"vac ni * day .

 N) chall"n," (9"rts strain$ 10+ E)/0 !"r bird$ by i# day 18.

 N) chall"n," ass"ss"nt day 2.

Page 8: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 8/17

:

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

%,% inde in 11-day old SPF birds on $32 (study no.2)

0

0/1

0/2

0/3

0/

0/!

0/"

0/#

%% indeopetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ +

*nterediate

ot

Page 9: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 9/17

10

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

*%$ Serolo&y curve in 11-day old SPF birds (study no.2)

0

1

23

!

"

#

10

11

12

13

0 1 32

$ays of the study

   *   %   $         t   i   t  r  e   (   i  n   l  o  &

   2   )

opetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ + ontrols

*

*

*: statistical di fference

*%$ vaccination

Page 10: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 10/17

11

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

$ Serolo&y curve in 11-day old SPF birds

0

1

2

3

!

"

#

0 1 32

$ays of the study

      $   0   *   t   i   t  r  e   (   i  n   l  o  &   2   )

op 1 4 5ni + op 2 4 5ni + op 3 4 5ni + op 4 5ni + evac *%$ + 4 5ni + evac 5ni + ontrols

*

*: statistical difference

*%$ vaccination $ vaccination

Page 11: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 11/17

12

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

$ challen&e in 11-day old SPF birds100 100 100 100 100 100

0

0

10

20

30

0

!0

"0

#0

0

0

100

   P  r  o   t  e  c   t   i  o  n  r  a   t  e   (   6   )

op 1 4 5ni + op 2 4 5ni + op 3 4 5ni + op 4 5ni + evac *%$ + 4 5ni + evac 5ni + SPF controls

$0, *%$ vaccination

$, $ vaccination

$1, $ challen&e

$32, $ challen&e

assessent

Page 12: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 12/17

1

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

7ise in * titre follo8in& $ challen&e in 11-day old SPF birds

0

0/!

1

1/!

2

2/!

3

3/!

   $   3   2   t   i   t  r  e   i  n  c   h  a   l   l  e  n  &  e   d  -

   $   3   2   t   i   t  r  e   i  n  u  n  c   h  a   l   l  e  n  &  e   d

   b   i  r   d  s

op 1 4 5ni + op 2 4 5ni + op 3 4 5ni + op 4 5ni + evac *%$ + 4 5ni + evac 5ni +

$0, *%$ vaccination

$, $ vaccination

$1, $ challen&e

$32, $ challen&e assessent

Page 13: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 13/17

Page 14: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 14/17

1/

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

Stud !o.) #D$%()0(&&) $. /ala- safet and efficac in commercialbroilers

'o"rcial broil"rs$ ocularly vaccinat"d at 17 days o a," (%); <N

titr" hatch 12.8$ and 17 d : lo,2# with (12/ birds !"r ,rou!3 1+/

controls#• Nobilis 228E (co!"titor 1#

• ;bic %& (co!"titor 2#

• Poulvac &ursa Plus (co!"titor #

• &) &l"n (co!"titor #

• '"vac &) *

vv&) chall"n,"$ %O9: strain$ 10 E)/0 !"r bird (20 birds !"r ,rou!#$

oral rout".

Page 15: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 15/17

1+

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

evac *%$ + in broilers, coparison to copetitors, &ro8th

0

!00

1000

1!00

2000

2!00

3000

1 21 2 3! 2

9&e of the chic:ens (days)

   9  v  e  r  a  &  e   b  o   d  y  8  e   i  &

   h   t   (  &   )

opetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ + ontrol

accination at 1# days

of a&e

Page 16: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 16/17

17

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

evac *%$ + in broilers, coparison to copetitors, vv*%$ challen&eresults

0

10

20

30

0

!0

"0

#0

0

0

100

1st challen&e ($2) 2nd challen&e ($32)

irus replication in the bursa days after challen&e

   '     t  e  n   t  o   f   b  u  r  s

  a

   i  n  v  o   l  v  e    e  n   t   i  n   6   )

opetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ + ontrol

Page 17: i Bd Compar Compet Trials

7/23/2019 i Bd Compar Compet Trials

http://slidepdf.com/reader/full/i-bd-compar-compet-trials 17/17

1:

Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors

%ain conclusions

• '"vac &) * is sa" on th" ,rowth o th" co"rcial broil"rs.

• Followin, th" "arli"st chall"n," (7 days !-v$ birds a,"d 2 days#$

'"vac &) * (and &) &l"n# !rot"ct"d th" bursa3 228E$ %&$ or

Poulvac &ursa Plus did not.

• Followin, th" lat" chall"n," (1/ days !-v$ birds a,"d 2 days#$

'"vac &) * (and %& and Poulvac &ursa Plus# !rot"ct"d a,ainstilln"ss$ as "vid"nc"d by th" body w"i,ht ,ain3 &) &l"n or 228E

did not. ;ll vaccin"s siilarly !rot"ct"d th" bursa.